Mattern Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$256K Buy
1,633
+33
+2% +$4.95K 0.04% 160
2026
Q1
$244K Sell
1,600
-16
-1% -$2.45K 0.05% 137
2025
Q4
$223K Sell
1,616
-93
-5% -$12.2K 0.04% 145
2025
Q3
$219K Hold
1,709
0.04% 149
2025
Q2
$207K Buy
+1,709
New +$193K 0.04% 156
2024
Q4
Sell
-3,325
Closed -$382K 177
2024
Q3
$382K Sell
3,325
-74
-2% -$8.4K 0.08% 125
2024
Q2
$362K Sell
3,399
-433
-11% -$43.5K 0.09% 126
2024
Q1
$371K Hold
3,832
0.09% 128
2023
Q4
$387K Sell
3,832
-53
-1% -$5.12K 0.1% 124
2023
Q3
$396K Sell
3,885
-12
-0.3% -$1.22K 0.12% 117
2023
Q2
$393K Sell
3,897
-53
-1% -$5.3K 0.11% 119
2023
Q1
$363K Sell
3,950
-79
-2% -$6.9K 0.12% 128
2022
Q4
$366K Hold
4,029
0.15% 118
2022
Q3
$306K Hold
4,029
0.12% 120
2022
Q2
$341K Hold
4,029
0.13% 111
2022
Q1
$354K Sell
4,029
-85
-2% -$7.36K 0.12% 114
2021
Q4
$360K Sell
4,114
-446
-10% -$37K 0.11% 125
2021
Q3
$373K Sell
4,560
-535
-11% -$48.1K 0.13% 123
2021
Q2
$467K Sell
5,095
-759
-13% -$67.6K 0.15% 117
2021
Q1
$500K Sell
5,854
-5,638
-49% -$506K 0.18% 105
2020
Q4
$1.08M Sell
11,492
-872
-7% -$76.2K 0.41% 72
2020
Q3
$1.07M Sell
12,364
-636
-5% -$55.1K 0.46% 66
2020
Q2
$1.14M Buy
13,000
+1,600
+14% +$138K 0.55% 58
2020
Q1
$940K Buy
11,400
+1,245
+12% +$111K 0.68% 50
2019
Q4
$962K Buy
+10,155
New +$911K 0.58% 68

Other funds holding NVS

Mattern Wealth Management's NVS Position: Q2 2026 in Review

Mattern Wealth Management increased its Novartis (NVS) stake by 2.1% in Q2 2026, buying an estimated $4.95K and bringing the position to 1,633 shares worth $256K. The position accounts for 0.04% of the portfolio, ranked #160.

Mattern Wealth Management first reported a position in NVS in Q4 2019 and has held it in 25 quarters since. The position peaked at $1.14M in Q2 2020. 1,614 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Mattern Wealth Management held 1,633 shares of Novartis worth $256K as of Q2 2026.
  • Mattern Wealth Management bought 33 Novartis shares in Q2 2026, an estimated $4.95K.
  • Novartis made up 0.04% of Mattern Wealth Management's portfolio in Q2 2026, its #160 holding.
  • Mattern Wealth Management first reported a position in Novartis in Q4 2019 and has held it in 25 quarters since.
  • Mattern Wealth Management's Novartis position peaked at $1.14M in Q2 2020.
  • 1,614 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Mattern Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.